Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
8 Sep, 26
This 2026 GOLD report is an evidence-based strategy document that provides key insights on prevention, diagnosis and management of COPD.
7 Sep, 26
The recently published ESC/ERA guidelines on CVD-CKD management emphasize the critical heart-kidney connection, advocating early CKD detection & evidence-based strategies for prevention, diagnosis, & treatment to reduce CV & renal disease burden.
10 Sep, 26
A 73-year-old man with COPD presented with worsening breathlessness, wheezing, and yellow sputum. Imaging revealed pneumonia and a right lung tumor in the setting of AECOPD. Click here to read the treatment.
28 Aug, 26
Chest
- Eosinophilic AE-COPD (blood eosinophils ≥300/μL within 3 days before to 1 day after the event), was associated with a significantly lower 1-year risk of major adverse cardiovascular events vs non-eosinophilic AE-COPD
- Eosinophilic AE-COPD was linked to reduced risks of heart failure, myocardial infarction, stroke, arrhythmias, and mortality, highlighting eosinophil count as a valuable cardiovascular risk biomarker.
28 Aug, 26
Diabetes Care.
- 4693 women followed for 10-14 yrs postpartum, showed GDM these subtypes: insulin-deficient (3%), insulin-resistant (9%), mixed-defect (1.6%), & unclassified (0.7%)
- Insulin-deficient, insulin-resistant, & mixed-defect GDM were linked to higher risk of prediabetes/diabetes vs no GDM (RR 2.14 to 2.88), metabolic syndrome, & higher predicted CVD risk; dyslipidemia was significant only with insulin-resistant GDM.
27 Aug, 26
Lancet Prim Care.
- Amongst a multinational cohort of 5.84 million adults initiating antihypertensive therapy, 1.9% suffered with ADHD
- ADHD was associated with higher risk of MACE (HR:1.31, 95% CI 1.18-1.45) & all-cause mortality (HR:2.83, 95% CI 2.07-3.87)
- After adjustment for psychiatric/cardiometabolic comorbidities, risks attenuated
- ADHD medication was not associated with MACE (HR 1.00) or mortality (HR 0.96)
7 Sep, 26
Featured

8 Sep, 26

27 Aug, 26

24 Aug, 26
















